I would <i>love</i> to know how they are going to do this. The start-up and on-going costs of maintaining a pharmaceutical manufacturing facility are enormous. I would guess it would take decades for them to ever break even on it. In particular, the shortages out there are rarely constant; one year one drug has shortages, next year it's another. Shifting production would be time consuming as hell.<p>Now, they could possibly pay a contract research organization (CRO) to manufacturer the drug, but the regulatory costs are still enormous. A new generic drug (i.e. a new manufacturer) has to submit an aNDA to the FDA (of which there is a massive backlog). There are CROs who are able to meet all the regulatory requirements, but a huge amount of work still fall on the manufacturer.